Real-World Analysis

Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records
On the basis of the results from CLEOPATRA, pertuzumab plus trastuzumab and chemotherapy is the first-line standard of care for human …
DOI
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records
Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study
Trastuzumab emtansine (T-DM1) has demonstrated improvements in survival and neurological symptoms in patients with breast cancer with …
DOI
Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma
Immune checkpoint inhibitors (CPIs) have expanded treatment options for patients with solid tumors. Systemic corticosteroids (CSs) have …
DOI
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma
Association of systemic corticosteroids with overall survival in patients receiving cancer immunotherapy for advanced melanoma, non-small cell lung cancer or urothelial cancer in routine clinical practice
Corticosteroids (CS) are often prescribed for patients (pts) with cancer to alleviate disease symptoms, manage treatment-related …
DOI
The Value of Novel Immuno-Oncology Treatments
Objectives-To assess the value to society of improved survival from novel immuno-oncology (I-O) treatments. Study Design-Case studies …
Link
The Value of Novel Immuno-Oncology Treatments
Measuring Sarcopenia Severity in Older Adults and the Value of Effective Interventions
Little is known about the severity and long-term health and economic consequences of sarcopenia. We developed a sarcopenia index to …
DOI
Measuring Sarcopenia Severity in Older Adults and the Value of Effective Interventions
Geographic Variation in Diagnostic Ability and Quality of Care Metrics: A Case Study of Ankylosing Spondylitis and Low Back Pain
Studies examining geographic variation in care for low back pain often focus on process and outcome measures conditional on patient …
DOI
Geographic Variation in Diagnostic Ability and Quality of Care Metrics: A Case Study of Ankylosing Spondylitis and Low Back Pain
Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis
There is considerable push to improve value in health care by simultaneously increasing quality while lowering or containing costs. …
DOI
Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis
Reconsidering the Economic Value of Multiple Sclerosis Therapies
Objectives-To illustrate a more comprehensive view of value associated with medicines treating a highly severe illness and to apply …
Link
Reconsidering the Economic Value of Multiple Sclerosis Therapies
Is Friendship Network Weight Status Associated with One’s Own Psychological Well-being? It Depends on One’s Own Weight Status
Drawing on multiple theoretical perspectives (e.g., social comparison theory, reward theory, evolutionary theory), the present research …
DOI